8-K/A

FORM 8-K/A

Company: Eloxx Pharmaceuticals, Inc.
Filed: July 25, 2014
Period of Report: May 16, 2014
Accession Number: 0001144204-14-044964

View Document ↗ View on SEC.gov ↗